BioFish Holding AS Income Statement

Financials in millions NOK. Fiscal year is January - December.

Millions NOK. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '24 Sep 30, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Revenue	36.67	47.68	20.24	18.33	30.92
Revenue Growth (YoY)	-31.32%	135.55%	10.44%	-40.73%	-
Cost of Revenue	30.75	42.83	21.23	11.4	19.37
Gross Profit	5.92	4.85	-0.98	6.93	11.55
Selling, General & Admin	15.57	7.56	5.02	2.12	4.3
Other Operating Expenses	8.95	6.7	9.24	12.28	-
Operating Expenses	37.03	20.51	14.77	14.8	4.72
Operating Income	-31.11	-15.66	-15.75	-7.87	6.83
Interest Expense	-6.59	-1.77	-0.88	-0.13	-
Interest & Investment Income	-	-	-	0.09	1.94
Other Non Operating Income (Expenses)	0.02	-0.4	0.15	-0	-
Pretax Income	-37.63	-17.83	-16.48	-7.91	8.77
Income Tax Expense	0	0	-1.59	-2.12	1.96
Net Income	-37.63	-17.83	-14.89	-5.79	6.81
Net Income to Common	-37.63	-17.83	-14.89	-5.79	6.81
Shares Outstanding (Basic)	-	88	13	-	-
Shares Outstanding (Diluted)	-	88	13	-	-
Shares Change (YoY)	-	559.17%	-	-	-
EPS (Basic)	-	-0.20	-1.11	-	-
EPS (Diluted)	-	-0.20	-1.11	-	-
Free Cash Flow	-42.51	-64.77	-44.6	-100.82	-
Free Cash Flow Per Share	-	-0.73	-3.33	-	-
Gross Margin	16.14%	10.18%	-4.85%	37.80%	37.35%
Operating Margin	-84.85%	-32.83%	-77.78%	-42.95%	22.09%
Profit Margin	-102.63%	-37.39%	-73.56%	-31.57%	22.04%
Free Cash Flow Margin	-115.93%	-135.84%	-220.32%	-550.03%	-
EBITDA	-18.6	-9.41	-15.25	-7.47	7.25
EBITDA Margin	-50.73%	-19.73%	-75.31%	-40.77%	23.46%
D&A For EBITDA	12.51	6.25	0.5	0.4	0.42
EBIT	-31.11	-15.66	-15.75	-7.87	6.83
EBIT Margin	-84.85%	-32.83%	-77.78%	-42.95%	22.09%
Effective Tax Rate	-	-	-	-	22.30%
Revenue as Reported	-	-	-	18.33	-

Source: S&P Capital IQ. Standard template. Financial Sources.